Market header image

Bulletins

You are here

2016-0819 - Suspension - Pivotal Therapeutics Inc. (PVO)

August 17, 2016

Pivotal Therapeutics Inc. is in default of CSE requirements. Effective at market close, Pivotal Therapeutics, currently the subject of a Cease Trade Order, will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.

Date: Effective market close, August 17, 2016
Symbol: PVO

If you have any questions or require further information, or to be removed from the mailing list please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Advertisement

Publicité

Latest CSE News

Upcoming Events

05_28_Issues_Changes_Capital_Markets_Website

CSE Talks Issues & Changes in the Capital Markets

Tuesday, May 28, 2019 -
2:45pm to 5:00pm
06_04_2019_ACA_Northwest_Website

2019 ACA Northwest Regional Meeting

Tuesday, June 4, 2019 (All day) to Wednesday, June 5, 2019 (All day)
06_05_TakeStock_Alberta_Website_v2

TakeStock Alberta

Wednesday, June 5, 2019 -
8:30am to 5:30pm

Advertisement

Publicité